This cohort study compares the AQUILA trial inclusion criteria and the 2/20/20 risk stratification model definitions for identifying individuals with smoldering multiple myeloma at high risk of progression.
JAMA Oncology published a clinical update in Oncology on 23 Apr 2026.
The item focuses on Identifying High-Risk Smoldering Multiple Myeloma for Early Intervention.
Review the original article for the full source wording and details.